Cardio Diagnostics Stock (NASDAQ:CDIO)
Previous Close
$3.72
52W Range
$3.40 - $53.10
50D Avg
$7.78
200D Avg
$12.20
Market Cap
$6.76M
Avg Vol (3M)
$58.72K
Beta
3.06
Div Yield
-
CDIO Company Profile
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.